Greenwich Associates says that US institutional investors are increasing their use of equity derivatives overall, though their use of some complex products is waning.According to the Connecticut-based consultancy, single-stock listed options, vanilla over-the-counter (OTC) options, exchange traded funds (ETFs), and equity swaps are coming into more widespread use. ETFs, for example, are now used by 75% of the investors it recently surveyed - 18% more than two years ago.
John Colon, a consultant at Connecticut-based Greenwich Associates said the growing use of equity derivatives across various strategies suggests a rising number of institutions are using the instruments as substitutes for cash equity trading.
Investors are opting for derivatives because of the ease with which the instruments help them gain leverage and anonymity, alongside beneficial tax treatment, Greenwich said.
However, US institutional investors’ use of some complex products, such as variance swaps and fund-linked and index-based products, has dropped by 20% during the past year. In contrast, European institutional investors have increased their use of tailored OTC, securitised, and hybrid derivatives by 15% over the same period.
This growth has been largely driven off the back of the popularity of structured products with the European retail and high-net worth (HNW) clients of dealers in Europe. According to Greenwich, only 5% of US dealers on-sell structured products to their retail and HNW client base.
Topics: Greenwich Associates
More on Exchange-traded products
A crackdown on margin financing strengthens bearish sentiment
Tax treaties likely to save ETF providers from a swingeing retrospective bill
Source launches European Nasdaq Biotech Ucits ETF
Multi-issuer platforms a growing alternative to listed exchanges
Sign up for Risk.net email alerts
Sponsored video: MarketAxess
Sponsored video: Tradeweb
Multifonds talks to Custody Risk on being nominated for the Post-Trade Technology Vendor of the Year at the Custody Risk Awards 2014
Sponsored webinar: IBM Risk Analytics
There are no comments submitted yet. Do you have an interesting opinion? Then be the first to post a comment.